A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy

Purpose

The researchers are doing this study to look at the health outcomes of people with advanced ovarian cancer who have a second look laparoscopy (SLL) after they complete their first course of chemotherapy. The researchers will compare the health outcomes of people who have minimal residual disease (MRD-small amounts of cancer cells in the body after a person receives treatment) at the time of SLL with the health outcomes of people who do not have MRD at the time of SLL. The researchers are also doing this study to determine if SLL is safe and practical (feasible) in people with advanced ovarian cancer who have completed the first course of therapy for their disease.

Condition

  • Ovarian Cancer

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients assigned female at birth≥ 18 years of age - Suspected or known stage III-IV epithelial ovarian cancer for which the patient has undergone, or is planned to undergo, attempted primary or interval debulking surgery - Homologous Recombination Deficiency testing should be planned to be completed prior to completion of initial platinum/taxane chemotherapy. HRD testing can be determined using : - Confirmation of deleterious Somatic or Germline BRCA mutation - CLIA certified test for HRD - Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial

Exclusion Criteria

  • Patients with the inability to swallow oral medications or impaired gastrointestinal absorption due to gastrectomy or drainage gastrostomy tube - Patients receiving standard of care or investigational protocol directed treatment are eligible for this study, with the exception of protocol directed treatment which would prohibit the SLL surgery from being performed

Study Design

Phase
Phase 2
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Intervention Model Description
This is a prospective study for biospecimen collection during standard of care procedures and during second look laparoscopy (SLL), which constitutes the only investigational procedure in this study.
Primary Purpose
Diagnostic
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Second Look Laparoscopy (SLL)
Patients will be treated with standard of care observation or maintenance therapy as per investigator decision.The only investigational intervention performed through this study is the SLL.
  • Procedure: Second Look Laparoscopy
    Second Look Laparoscopy (SLL)

Recruiting Locations

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge 5095409, New Jersey 5101760 07920
Contact:
Rachel Grisham, MD
646-888-4653

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown 5101170, New Jersey 5101760 07748
Contact:
Rachel Grisham, MD
646-888-4653

Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale 5101361, New Jersey 5101760 07645
Contact:
Rachel Grisham, MD
646-888-4653

Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities)
Commack 5113412, New York 5128638 11725
Contact:
Rachel Grisham, MD
646-888-4653

Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison 5120095, New York 5128638 10604
Contact:
Rachel Grisham, MD
646-888-4653

Memorial Sloan Kettering Cancer Center
New York 5128581, New York 5128638 10065
Contact:
Rachel Grisham, MD
646-888-4653

Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale 5141927, New York 5128638 11553
Contact:
Rachel Grisham, MD
646-888-4653

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Rachel Grisham, MD
646-888-4653
grishamr@mskcc.org